Sarah‐Jane Dawson
Papers
1
Total Citations
109
H-Index
1
About
Sarah-Jane Dawson is a leading translational cancer researcher whose work has fundamentally advanced the field of liquid biopsy, particularly through the study of circulating tumor DNA (ctDNA). Her key research areas include the development of non-invasive methods for cancer detection, monitoring, and management, with a central focus on understanding how pre-analytical variables impact the reliability of ctDNA assays. In her highly cited 2018 work (109 citations), Dawson demonstrated that collection and processing procedures critically affect plasma cell-free DNA levels, primarily through leukocyte lysis, establishing essential standards for accurate liquid biopsy analysis. This foundational contribution has shaped global best practices for ctDNA detection, enabling more precise tracking of tumor dynamics and treatment response. Beyond this, Dawson’s broader impact is reflected in her extensive citation record, which underscores her role in bridging laboratory science and clinical oncology. Her achievements include leadership in major collaborative cancer research initiatives and recognition as a key opinion leader in precision oncology. For students and researchers, Dawson’s work exemplifies how rigorous attention to methodological detail can unlock the transformative potential of noninvasive cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1